share_log

DJ ImmunoCellular Therapeutics L, Inst Holders, 4Q 2018 (IMUC)

Dow Jones Newswires ·  Jan 22, 2019 04:09

DJ ImmunoCellular Therapeutics L, Inst Holders, 4Q 2018 (IMUC)

The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended December 31, 2018, listed by holding size. The list represents up to 50 of the largest holders in the company.

Note: Unless otherwise mentioned the reporting date is 12/31/2018


Institution Shares Shares % Last
Held Changed Held Report
Renaissance Technologies LLC 1,211,604 133,200 2.890 09/30
The Vanguard Group Inc. 285,154 285,154 0.680 09/30
Wedbush Securities Inc. (Inve 86,530 86,530 0.206 09/30
Citadel Advisors LLC 69,746 69,746 0.166 09/30
Two Sigma Securities LLC 61,448 61,448 0.147 09/30
UBS Securities LLC 58,540 58,540 0.140 09/30
First Allied Advisory Services 40,000 0 0.095 09/30
G1 Execution Services LLC 32,871 32,871 0.078 09/30
Invesco Capital Management LLC 10,992 (1,373) 0.026 09/30
NEXT Financial Group Inc. 3,000 3,000 0.007 09/30
BlackRock Fund Advisors 672 0 0.002 09/30
Tradewinds Capital Management 200 0 0.000 09/30
Wells Fargo Advisors Financial 125 0 0.000 09/30
Jacobi Capital Management LLC 125 0 0.000 09/30
Wells Fargo Clearing Services 125 125 0.000 09/30
Morgan Stanley Smith Barney LL 113 113 0.000 09/30
IFP Advisors Inc. 95 0 0.000 09/30
Honkamp Krueger Financial Serv 74 74 0.000 09/30
Rehmann Capital Advisory Group 69 0 0.000 09/30
Ancora Inverness LLC 50 50 0.000 09/30
Truvestments Capital LLC 50 50 0.000 09/30
Barclays Bank Plc (Private Ban 50 50 0.000 09/30
Certified Advisory Corp. 20 0 0.000 09/30
Financial Architects Inc. 1 0 0.000 09/30
Steward Partners Investment Ad 0 (125) 0.000 12/31
Virtu Financial BD LLC 0 (71,027) 0.000 12/31
13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2019. All Rights Reserved.

(END) Dow Jones Newswires

January 22, 2019 04:09 ET (09:09 GMT)

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment